Kleiter I, Jilg W, Bogdahn U, Steinbrecher A
Dept. of Neurology, University of Regensburg, Universitätsstr. 84, 93042, Regensburg, Germany.
Infection. 2007 Feb;35(1):26-9. doi: 10.1007/s15010-006-6614-2.
Tick-borne encephalitis virus (TBEV) is a common cause of viral encephalitis in parts of Central and Eastern Europe. Active immunization results in a high rate of seroconversion and is the most effective measure of decreasing the incidence of tick-borne encephalitis (TBE). Currently, booster vaccinations are recommended every 3 years after completion of primary immunization. However, titers of neutralizing antibodies decline with time after vaccination and with age and thus may be insufficient to protect from disease in the elderly. We report on a 54-year-old patient who had received his last booster vaccination 3 years before developing a severe TBE with delayed induction and longterm persistence of anti-TBEV-IgM-antibodies.
蜱传脑炎病毒(TBEV)是中欧和东欧部分地区病毒性脑炎的常见病因。主动免疫可导致高血清转化率,是降低蜱传脑炎(TBE)发病率的最有效措施。目前,建议在完成初次免疫后每3年进行一次加强免疫。然而,中和抗体滴度会随着疫苗接种后的时间以及年龄增长而下降,因此可能不足以保护老年人免受疾病侵害。我们报告了一名54岁的患者,他在发生严重蜱传脑炎前3年接受了最后一次加强免疫,其抗TBEV-IgM抗体出现延迟诱导且长期持续存在。